Z-LVG-CHN2
Names
Biological Activity
[Description]:
Z-LVG-CHN2 is a cell-permeable and irreversible inhibitor of cysteine proteinase. Z-LVG-CHN2 is a tripeptide derivative and mimics part of the human cysteine proteinase-binding center. Z-LVG-CHN2 displays an inhibition on HSV whereas no significant effect on poliovirus replication. Z-LVG-CHN2 effectively blocks SARS-COV-2 replication (EC50=190 nM) via inhibition of SARS-COV-2 3CL pro protease[3].
[Related Catalog]:
[Target]
EC50: 190 nM (SAR-COV-2)[3]
[In Vitro]
Z-LVG-CHN2 (0-10 μM; pre-treated for 16 h) inhibits antiviral activities in a discernable dose-dependent manner in Vero E6 cells by designed to capture multicycle replication, exhibiting an EC50 value of 0.19 μM[1]/ Cell Viability Assay[3] Cell Line: Vero E6 cells Concentration: 0.001 μM, 0.003 μM, 0.1 μM, 0.3 μM, 1 μM, 2.5 μM Incubation Time: Pre-treated for 16 h and then cultured for 24 hours Result: Inhibited SARS-COV-2 virus replication in a dose-dependent manner.
[References]
Chemical & Physical Properties
[ Molecular Formula ]:
C22H31N5O5
[ Molecular Weight ]:
445.51
[ Storage condition ]:
−20°C
Safety Information
[ Hazard Codes ]:
Xi
[ WGK Germany ]:
3
Related Compounds
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.